Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells
Open Access
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 87 (6) , 582-590
- https://doi.org/10.1038/labinvest.3700540
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumorsThe Journal of Experimental Medicine, 2005
- Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell DeathPublished by Elsevier ,2004
- An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infectionHepatology, 2004
- Human CD4+CD25+ regulatory T cellsSeminars in Immunology, 2004
- Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectHepatology, 2003
- Long–Term Interleukin 10 Therapy in Chronic Hepatitis C Patients Has A Proviral and Anti–Inflammatory EffectHepatology, 2003
- CD4+CD25+ regulatory T cells control Leishmania major persistence and immunityNature, 2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cellsInternational Journal of Cancer, 1993